Literature DB >> 18326967

Beta-blockers in the treatment of hypertension: new data, new directions.

Michael A Weber1, George L Bakris, Thomas D Giles, Franz H Messerli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326967      PMCID: PMC8110173          DOI: 10.1111/j.1751-7176.2008.07843.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  36 in total

Review 1.  Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Authors:  Lars Hjalmar Lindholm; Bo Carlberg; Ola Samuelsson
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

2.  Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Authors:  Bryan Williams; Peter S Lacy; Simon M Thom; Kennedy Cruickshank; Alice Stanton; David Collier; Alun D Hughes; H Thurston; Michael O'Rourke
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

3.  Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation.

Authors:  Anna Fratta Pasini; Ulisse Garbin; Maria Cristina Nava; Chiara Stranieri; Anna Davoli; Tatsuya Sawamura; Vincenzo Lo Cascio; Luciano Cominacini
Journal:  J Hypertens       Date:  2005-03       Impact factor: 4.844

4.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors:  L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

5.  Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study.

Authors:  J Wikstrand; I Warnold; J Tuomilehto; G Olsson; H J Barber; K Eliasson; D Elmfeldt; B Jastrup; N B Karatzas; J Leer
Journal:  Hypertension       Date:  1991-04       Impact factor: 10.190

6.  Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.

Authors:  Kurt Stoschitzky; Gergana Stoschitzky; Helmut Brussee; Claudia Bonelli; Harald Dobnig
Journal:  Cardiology       Date:  2006-05-04       Impact factor: 1.869

7.  Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

Authors:  J M Brophy; L Joseph; J L Rouleau
Journal:  Ann Intern Med       Date:  2001-04-03       Impact factor: 25.391

8.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

9.  Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.

Authors:  H O Lithell
Journal:  Diabetes Care       Date:  1991-03       Impact factor: 19.112

10.  Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.

Authors:  Michael A Weber; George L Bakris; Elizabeth A Tarka; Malini Iyengar; Richard Fleck; Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

View more
  3 in total

1.  Cardiovascular responses and differential changes in mitogen-activated protein kinases following repeated episodes of binge drinking.

Authors:  Lianzhi Gu; Anne M Fink; Shamim A K Chowdhury; David L Geenen; Mariann R Piano
Journal:  Alcohol Alcohol       Date:  2012-08-08       Impact factor: 2.826

Review 2.  Beta-blocker use for the stages of heart failure.

Authors:  Marc Klapholz
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

Review 3.  Realities of newer beta-blockers for the management of hypertension.

Authors:  Camila Manrique; Thomas D Giles; Keith C Ferdinand; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-07       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.